Schafer Boeder

Also affiliated with La Jolla Alcohol Research, University of California San Diego Medical Center, Group for the Analysis of Development

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes”.

COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes

Diabetes Care(2020)10.2337/dc20-2260

N/A

6.6DataRank · unranked

263 citations

James C. Slaughter, Sara H. Duffus, T. Jordan Smith, Lauren M. LeStourgeon, Sarah S. Jaser +7 more

Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526–532

Diabetes Care(2020)10.2337/dci21-0005

N/A

0DataRank · unranked

1 citations

James C. Slaughter, Sara H. Duffus, T. Jordan Smith, Lauren M. LeStourgeon, Sarah S. Jaser +7 more

Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial

Nature Medicine(2022)10.1038/s41591-022-02011-x

N/A

0DataRank · unranked

57 citations

Schafer Boeder, Mark P. Christiansen, Douglas Denham, Timothy S. Bailey, Halis Kaan Aktürk +11 more

Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia

Diabetes Obesity and Metabolism(2023)10.1111/dom.15070

N/A

0DataRank · unranked

41 citations

Schafer Boeder, Sunder Mudaliar, Erin R. Giovannetti, Robert R. Henry, Jeremy Pettus +1 more

Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial

Diabetes Care(2024)10.2337/dc24-0212

N/A

0DataRank · unranked

24 citations

Robert L. Thomas, Melissa J. Le Roux, Erin R. Giovannetti, Justin M. Gregory, Jeremy Pettus +1 more

Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes

Diabetes Care(2024)10.2337/dc23-2501

N/A

0DataRank · unranked

7 citations

Schafer Boeder, Vala Hamidi, Erin R. Giovannetti, Justin M. Gregory, Jeremy Pettus +1 more

Continuous Glucose Monitoring–Guided Insulin Infusion in Critically Ill Patients Promotes Safety, Improves Time Efficiency, and Enhances Provider Satisfaction

Endocrine Practice(2025)10.1016/j.eprac.2025.05.751

N/A

0DataRank · unranked

5 citations

RACHAEL O. LEE, Robert L. Thomas, Tamar Wolinsky, Adrianne V. Talbot, Rabia Ali +4 more